key: cord-1004430-u9c1kfwa
authors: Capraro, Alexander; Wong, Sharon L; Adhikari, Anurag; Allan, Katelin M; Patel, Hardip R; Zhong, Ling; Raftery, Mark; Jaffe, Adam; Yeang, Malinna; Aggarwal, Anupriya; Wu, Lindsay; Pandzic, Elvis; Whan, Renee M; Turville, Stuart; Vittorio, Orazio; Bull, Rowena A; Kaakoush, Nadeem; Rawlinson, William D; Tedla, Nicodemus; Vafaee, Fatemeh; Waters, Shafagh A
title: Ageing impairs the airway epithelium defence response to SARS-CoV-2
date: 2021-04-06
journal: bioRxiv
DOI: 10.1101/2021.04.05.437453
sha: b5db9ab16290a5d6cd9bb04ba3e74f3a97789380
doc_id: 1004430
cord_uid: u9c1kfwa

Age-dependent differences in the clinical response to SARS-CoV-2 infection is well-documented1–3 however the underlying molecular mechanisms involved are poorly understood. We infected fully differentiated human nasal epithelium cultures derived from healthy children (1-12 years old), young adults (26-34 years old) and older adults (56-62 years old) with SARS-COV-2 to identify age-related cell-intrinsic differences that may influence viral entry, replication and host defence response. We integrated imaging, transcriptomics, proteomics and biochemical assays revealing age-related changes in transcriptional regulation that impact viral replication, effectiveness of host responses and therapeutic drug targets. Viral load was lowest in infected older adult cultures despite the highest expression of SARS-CoV-2 entry and detection factors. We showed this was likely due to lower expression of hijacked host machinery essential for viral replication. Unlike the nasal epithelium of young adults and children, global host response and induction of the interferon signalling was profoundly impaired in older adults, which preferentially expressed proinflammatory cytokines mirroring the “cytokine storm” seen in severe COVID-194,5. In silico screening of our virus-host-drug network identified drug classes with higher efficacy in older adults. Collectively, our data suggests that cellular alterations that occur during ageing impact the ability for the host nasal epithelium to respond to SARS-CoV-2 infection which could guide future therapeutic strategies.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic 6 . Clinical presentation is highly heterogeneous, ranging from asymptomatic infection to critically ill patients with respiratory failure 7 . The single greatest risk factor for disease severity and mortality is age. Children experience relatively mild symptoms 1, 2, [8] [9] [10] , with a case fatality rate of 0.026% under the age of 9, compared to an increased risk of severe illness in older groups, with a case fatality rate of over 13% in those aged over 80 3 . This trend was also observed during the 2002-4 SARS epidemic 11 , and contrasts the 1918 H1N1 and 1968 H3N2 influenza epidemics, where mortality was concentrated in younger adults 8 . Despite this clear trend, the reasons for increased mortality from COVID-19 with ageing are uncertain.

The airway epithelium is the first site exposed to SARS-CoV-2 and is central to the host defence and innate immune response to infection. Ciliated and goblet cells are preferentially infected as they have the highest expression of the SARS-CoV-2 entry receptor angiotensin-converting enzyme 2 (ACE2) 12 . Upon entry, viral RNA normally triggers an innate immune response involving the transcription of antiviral and proinflammatory cytokines 13 including type I and III interferons (IFNs) that induce the expression of IFN-stimulated genes (ISG) which restrict viral replication 14 . A key feature of coronaviruses is the ability to evade this innate immune response, primarily through the inhibition of IFN production and downstream signalling. This aberrant immune response is characterised by cytokine release syndrome (CRS) and dysregulated interferon response 4, 5, 15, 16 , resulting in secondary bacterial pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, and death 17 . Explanations for age-related differences in COVID-19 outcomes include differential expression of ACE2, altered responses from circulating immune cells, background co-morbidities and low-grade chronic inflammation ("inflammaging"). However, whether cell-intrinsic changes in the airway epithelium that occur with ageing contribute to these differences is unclear.

To compare age-dependent mucosal innate immune responses to SARS-CoV-2 infection, we established well-differentiated human nasal epithelial cultures (hNEC) at air liquid interface (ALI) from nasal brushings of 13 participants, comprising six children (5.40±3.97 y/o), four young adults (31.89±4.14 y/o), and three older adults (58.14±3.30 y/o) (Fig. 1A, Table S1 ). Since SARS-CoV-2 displays a decreasing infectivity gradient from the upper to the lower respiratory tract 20 , hNECs from the child participants were also compared with participant-matched bronchial epithelial cells (hBEC). We confirmed the differentiated cultures retained the expected pseudostratified morphology of mucociliary epithelium (Extended Data Fig. S1A ) and function. We observed a decline in ciliary beat frequency (CBF) in cultures from older adults that is consistent with known physiological changes with ageing 21,22 (Fig. 1B) . This provided functional evidence that the age-related properties of the hNEC participant was retained. In addition, both transcriptome and proteome mock-infected data showed significant age-dependent correlation with positive (adhesion and stress response) and negative (mitochondria and replication) age-associated genes reported for the ageing human lung 23 (Extended Data Fig. 1B-C) .

Next, the apical surface of these cultures was infected with SARS-CoV-2 at 0.2 multiplicity of infection (MOI). Viral entry and internalisation was confirmed at 72 hours post-infection (hpi) using immunofluorescence (IF) staining of the viral nucleocapsid protein (SARS-CoV-2 N). The protein was present within the cytoplasmic compartment and manifested in clusters which were limited to the apical top layer of cultures in all age groups (Fig. 1C) . Consistent with the decreasing infectivity gradient down the respiratory tract 20 , approximately 20% of the top layer of cells were positively stained for SARS-CoV-2_N in hNECs created from the adult and child participants, whereas only 8% of the top layer of child hBECs were positive (Fig. 1C, Table S3 ).

Viral load was assessed from infected cells using quantitative PCR (qPCR) targeting viral cDNA, RNA sequencing (RNA-seq) and protein quantification by LC/MS-MS. Surprisingly, viral transcript levels assessed by qPCR were significantly lower (p < 0.01) in hNECs from older adults than those of children and young adults (Fig. 1D) . This result was confirmed with RNA-seq with ~9% of reads from SARS-CoV-2 in hNECs from older adults compared to ~28% in children and young adults (Fig. 1E, Extended  Data Fig. 1D-E) , and by the differential abundance of SARS-CoV-2 proteins detected by unbiased proteomics (Extended Data Fig. 1F) . As with the results of viral staining and the gradient of infection observed clinically, SARS-CoV-2 transcription in hBECs were significantly lower than those in patient-matched hNECs despite infection at the same MOI ( Fig. 1C-E) . This demonstrates that ageing influences SARS-CoV-2 viral load 72 hpi in the hNEC model (Extended Results).

Given the age-dependent variation in viral load, we next surveyed global transcriptomic and proteomic responses to infection. A strong age-dependent response was evident when host transcriptional and proteomic profiles in SARS-CoV-2 infected cells were compared with their respective uninfected controls (Fig. 1F, Extended Data Fig. 2A-C, Table S4 , S5). Children and young adults hNECs displayed robust, global proteomic and transcriptional responses to SARS-CoV-2 infection, with 3,240 (20% of all expressed genes) and 2,466 (15%) differentially expressed genes (DEG), respectively. In contrast, the transcriptional response to infection in older adult hNECs was almost completely absent, with only 24 (0.015%) DEGs (Fig. 1F) . Even with a less stringent cut-off (p<0.05 rather than FDR<0.05), only 422 (2.6%) DEGs were identified (Fig. 1F ) This was unlikely due to the low viral load in the older adult hNECs as child hBECs with a similarly low viral load (~9% and ~12%, respectively; Fig. 1C -E) showed a robust transcriptional response to SARS-CoV-2 infection (DEGs=1,797, 11%; Fig. 1F , Extended Data Fig. 2A, Table S4 ). The proteomes of these samples followed a similar trend (Extended Data Fig. 2B -C, Table S5 ) and was highly correlated with transcript levels in both mock and SARS-CoV-2 infected cultures (Spearman's ρ=0.483 and 0.486, p<0.05, respectively; Extended Data Fig. 2D ).

Pathway enrichment analysis revealed similar responses in hNECs and hBECs from children and young adults hNECs, with upregulation of interferon signalling, innate and adaptive immune response, apoptosis, cytokine, and inflammatory response pathways, while antioxidant defence, oxidative phosphorylation, and fatty acid metabolism were reduced (Fig. 1G, Table S6 , S7). In older adults, only interferon signalling, and B cell signalling were altered (Fig. 1G) , however, the less stringent cut-off ( Fig. 1F ) expanded this to include hypercytokinemia (cytokine storm), coronavirus pathogenesis and viral recognition pathways (Extended Data Fig. 2E) . Notably, this trend was not restricted to coding transcripts, with differential expression of long non-coding RNAs (lncRNA) in young adult (127), child hNECs (164) and hBECs (92) compared to only a single lncRNA (RN7SL1, RNA component of signal recognition particle) differentially expressed in older adults (Extended Data Fig. 2F , Table S8 ; Extended Results). Pathway analysis of proteomics data revealed similar pathways, however, lower numbers of differentially expressed proteins (DEP) restricted interpretation (Fig. 1G, Table S7 ).

A key feature of coronaviruses is the ability to evade antiviral IFN signalling 16, 24 , with susceptibility to exogenous IFN treatment 16, 25 and the host ability to mount an IFN response important determinants of patient survival 26 . In line with this, type I (IFNB1) and type III (IFNL1, IFNL2) IFNs were induced by viral infection in cultures from children and young adults, but not in hNECs from older adults, with a similar trend observed for IFN regulatory factors (IRFs) ( Fig. 2A) . In accordance with this, IFN expression in SARS-CoV-2 infected cultures was moderately negatively correlated with age (Spearman's ρ=-0.499, p<0.05; Fig. 2B ). While IFN gene expression was strongly positively correlated with SARS-CoV-2 transcript expression across all age groups, the coefficient of determination was 20% lower in older adults compared to children and young adults suggesting that ageing leads to less effective induction of IFNs by SARS-CoV-2 (Fig. 2B) .

IFN induction was associated with the expression of several hundred IFN-stimulated genes (ISG; Fig.  2C , Extended Data Fig. 3A-B) . ISGs were grouped based on five functional clusters as defined by Mostafavi 27 ; RNA processing (C1 and C2), interferon regulation and antiviral function (C3), metabolic regulation (C4) and inflammation (C5). Cluster C1 and C2 was profoundly lower in older adults compared to other age groups (adjusted p-value<0.0001), which follows the common RNA virus strategy to inhibit host RNA processing to restrict the host antiviral response 28 . Despite an impaired IFN response in older adults, baseline expression of C3, C4 and C5 clusters were significantly higher in uninfected older adults (adjusted p-value < 0.0001), and all were increased upon infection when compared to their mock counterparts (adjusted p-value < 0.05). In contrast, the mean expression of genes in the inflammation cluster was significantly higher in older adult than both child cultures (adjusted p-value < 0.0001). Notably, this exaggerated response in older adult was elicited by a subset of only 14/552 ISGs (Extended Data Fig. 3A ), compared to the broad upregulation of ISGs in young adult (156/552) and child hNEC (132/552) and hBECs (109/552) with a similar trend in the ISG protein levels (Extended Data Fig. 3B , Extended Results).

Limited or delayed production of IFNs has been associated with a dysregulated immune response and the development of cytokine release syndrome in COVID-19 5, 29 . In line with this, cytokine expression was highest in hNECs from older adults under both infected and uninfected conditions (adjusted p-value<0.05; Fig. 2D ). While proteins involved in innate immune cell processes were identified in mass spectrometry-based profiling of the extracellular secretome, cytokines could not be detected (Fig. 2E , Table S9 ). Nine cytokines were detected in both mock and infected media using a 34-cytokine multiplex ELISA, with higher baseline IL-8 levels in older adults compared to young adults and children and significantly more IL-1α in secretome from older adult cultures (Fig. 2F) . The increased baseline inflammation in older adults is aligned with the presence of inflammaging 30 . Consistent with this and with previously described alterations in ageing lungs 31 , we identified 91 unique DEGs and 372 differentially expressed proteins in uninfected hNECs between the three age groups which were enriched for canonical pathways involved in cellular metabolism, stress response, and immune and inflammatory signalling (Fig. 2G , Table S10-13, Extended Results).

To identify factors that may cause differences in viral load among the age groups, we first assessed the host cell surface factors that influence viral recognition and internalisation. Ciliated and goblet cells are known to have the highest expression of SARS-CoV-2 entry receptors 12 . All cultures developed pseudostratified polarised epithelium composed of the major epithelial cell types. The virus was able to infect both ciliated (AcTub stain) and mucus secreting goblet cells (MUC5AC stain; Fig. 3A ). Celltype composition estimation using RNA-seq data showed an age-associated trend of higher abundance of mucus producing goblet cells and a lower abundance of ciliated cells in uninfected and infected cultures, suggesting a higher secretory phenotype with ascending age (Fig. 3B) . The same trend was observed in the proteome with significantly lower expression of ciliated cell protein markers in older adults (adjusted p-value<0.005, Fig. 3C ).

Expression of retinoic acid-inducible gene I-(RIG-I-) like receptors -crucial pattern recognition receptors which play essential roles in recognizing intracellular viral RNA -increased post SARS-CoV-2 infection in child and young adult cultures (Fig. 3D) . With the addition of toll-like receptors (TLR), a non-significant trend of increased mean expression of these receptors were observed with ascending age (Fig. 3D) . Recent studies suggest the SARS-CoV-2 entry factors ACE2 and TMPRSS2 32 are more highly expressed on goblet cells compared to ciliated cells 12, 33 . Although ACE2 showed 20% higher expression in older adults compared to child hNECs, this difference was not statistically significant (Fig. 3E) . Viral gene expression and ACE2 expression were not significantly correlated, with a negative correlation between TMPRSS2 expression and viral gene expression (Spearman's ρ=-0.678, p<0.05; Fig. 3F ). We then assessed other host factors potentially involved in entry of SARS-CoV-2 or those that are known to be involved in entry of other coronaviruses 12,34-36 and observed that expression was highest in older adults, followed by children then young adults (adjusted p<0.005) (Fig. 3E) . No significant difference in expression of these factors was observed between child hNECs and hBECs (Fig. 3E) . These data suggest that physiological differences in the expression of viral recognition and entry factors are poorly correlated to SARS-CoV-2 viral load and do not explain differences in viral entry and replication associated with ageing.

As obligate intracellular parasites, viruses require host cell components to replicate, translate and transport their proteins. We assessed the expression of host proteins that interact with the SARS-CoV-2 replication and transcription complex (RTC) and may impact its transcription 37 . Using a highconfidence protein-protein interaction map between host and SARS-CoV-2 proteins 38 , we assessed the gene expression of those proteins that interact with SARS-CoV-2 RTC. Mean gene expression of host proteins that interact with the RNA-dependant RNA polymerase (Nsp12) and its binding auxiliary factor (Nsp8) was significantly higher in hNECs from children compared to those from older adults following SARS-CoV-2 infection (Fig. 3G) . A moderately positive correlation between viral read counts and Nsp8 (Spearman's ρ=0.491, p<0.05) and Nsp12 (Spearman's ρ=0.418, p<0.05) interacting protein gene expression was observed (Fig. 3H) . These results suggest that age-dependent differences in the expression of SARS-CoV-2 interacting proteins may influence viral transcription. SARS-CoV-2 infection, through the function of Nsp16, disrupts host mRNA splicing which aids in the suppression of the interferon response 28 . Therefore, we investigated whether susceptibility to Nsp16-mediated RNA splicing suppression occurs in an age-dependent manner. While SARS-CoV-2 infection resulted in a significant increase in the proportion of retained introns in host mRNAs in child cultures (adjusted p-value<0.05), there were no significant differences between age groups (Fig. 3I) . Furthermore, retained intron proportions were moderately correlated with SARS-CoV-2 transcript expression (Spearman's ρ=0.486, p<0.05; Fig. 3J ), suggesting that Nsp16-mediated RNA splicing suppression occurs in a viral dose-dependent manner.

During ageing, a decline in transcriptional fidelity is thought to contribute to the senescence-associated secretory phenotype and low-grade chronic inflammation 39 . This idea is consistent with the increased inter-cell transcriptional heterogeneity observed in the human lung with ageing 31 . While inter-cell transcriptional heterogeneity could not be determined with bulk RNA-seq, our results showed intersample transcriptional heterogeneity increased with ageing under both mock and SARS-CoV-2 infected conditions (adjusted p-value<0.05; Fig. 3K ). The age-related increase in transcriptional heterogeneity could result in a varied and unpredictable response to SARS-CoV-2 infection. An unsupervised principal coordinate analysis on both the transcriptome and proteome illustrated this (Fig. 3L) . It showed that directional shifts post-SARS-CoV-2 infection were inconsistent in older adults compared to child and young adults, and Euclidean distances between centroids were smaller in older adults (0.0257) compared to child (0.0357) and young adult (0.0437). Therefore, the inherent age-related alterations in transcriptional control may lead to an inconsistent host response that is ineffective in launching an appropriate antiviral defence.

Drug repositioning has gained considerable interest during the COVID-19 pandemic to accelerate the identification and approval of beneficial therapeutic drugs. We assessed whether the age-specific transcriptional response of hNECs to SARS-CoV-2 infection may influence the efficacy of therapeutic agents by implementing a modified version of the COVID-19 Combinational Drug Repositioning (COVID-CDR) platform 40 . To screen for potential repositionable drugs across different age groups, we calculated the network proximity between drug targets and SARS-CoV-2-interacting host proteins as an unbiased measure of drug-disease relatedness. Drugs (drug targets) that are more proximal (closer) to disease agents (SARS-CoV-2 interacting proteins) are theoretically more effective than more distant drugs. Drugs were considered significantly proximal to SARS-CoV-2 interacting proteins if z-score < -2.0 and p-value < 0.01 (see Supplementary Information 1) .

We screened over 21,000 drugs listed in the DrugBank 41 and identified 108 significantly proximal drugs from 39 unique drug classes across all age groups (permutation p-value < 0.01; Fig. 4A-C, Table S14 ). Of these drugs, 52 have evidence for treating COVID-19 symptoms or are currently in clinical trials to treat COVID-19 (Table S14) . Older adults possessed the greatest number of proximal drugs, with child possessing the least (Fig. 4A) . Drug classes with more than 5 proximal drugs in all age groups were zinc compounds, antibiotics and anticancer drugs (Fig. 4B) . Within the anticancer drug class, the majority were tyrosine kinase inhibitors which were highly proximal to several SARS-CoV-2 proteins (Fig. 4C) . The trace metal drug classes of copper compounds and zinc compounds were identified in all age groups. In contrast, calcium compounds and aluminium compounds were exclusively identified in older adults. These results highlight that differences in the transcriptional response to SARS-CoV-2 due to ageing may impact the efficacy of therapeutic drugs for COVID-19 treatment.

Our study revealed that viral load and antiviral responses in nasal epithelium wane with advancing age. These differences do not result from the depletion of virus-susceptible cell populations or reduced expression of the SARS-CoV-2 receptor and entry factors. Rather, the expression of host proteins hijacked by the SARS-CoV-2 replication complex are significantly reduced with ageing. The induction of innate immunity during SARS-CoV-2 infection is dependent on viral growth kinetics, viral load and MOI. With a low MOI of 0.2 the antiviral IFN response was robustly induced in child and young adults, but not in older adults. Viral load alone is unlikely to explain differences in IFN induction as bronchial epithelial cells from children exhibited a robust innate immune response despite similarly low viral load as older adult hNECs.

IFN responses are crucial for antiviral defence and in determining disease severity of COVID-19 26 however SARS-CoV-2 and other coronaviruses are weak inducers of both type I and III IFN expression compared to other RNA viruses 5, 26 . Relative to the nasal epithelium of children and young adults, the IFN response was severely blunted in older adults with diminished expression of ISGs. RNA processing ISGs were lowly expressed in older adults suggesting that ageing epithelial cells may be more susceptible to viral strategies that disrupt host RNA transcription and processing. In contrast to older adults, both child and young adults executed type III IFN response accompanied by upregulation of IRFs and antiviral ISGs. Young adult hNECs were the only age group with a significant upregulation of type I IFNs (IFN-β) in response to SARS-CoV-2 infection. IFN-β is regulated in a feedback loop and the upregulation of its key negative regulators (USP18 and SOCS3) in young adults is likely indicative of a controlled response 44, 45 . Since type I IFN receptors (IFNAR) are ubiquitously expressed, this may result in a more systemic response than that elicited by type III IFNs.

Due to the single infection timepoint we could not determine whether interferon response is delayed or impaired in older adults. However, both impaired and delayed induction of IFNs elevate inflammation in the form of excessive proinflammatory cytokine production 26 . In support, we observed significantly higher expression of proinflammatory ISGs and cytokines such as neutrophil and monocyte chemoattractive chemokines in older adult derived hNECs compared to young adult and children. This resembled the "cytokine storm" associated with severe cases of COVID-19 17 . High congregation of neutrophils, key cells responsible for acute lung injury in COVID-19, could explain the increased incidence of lung injury in adults infected with SARS-CoV-2. Moreover, type III IFNs, which was absent in older adults, act negatively on neutrophils, suppressing their migration and invasion 46 and reducing the formation of neutrophil extracellular traps 47 and the excessive production of reactive oxygen species (ROS) 48 ; all of which occur in severe COVID-19 49, 50 . Additionally, the decreased IFN response in older adults could cause low immunity and increased chances of reinfection. This would have further implications on the efficacy of a SARS-CoV-2 vaccine in older adults. In fact, both type I and III IFN responses stimulate antibody production and dendritic cell activity, playing an important adjuvant role for vaccine response 51 . On the other hand, young adults with both I and III IFN responses could present a better immunological memory after infection or vaccination.

We postulate that intrinsic changes in gene expression that occur with ageing alter the epithelial microenvironment in a manner that primes the cell to launch a cytotoxic proinflammatory and IFNindependent antiviral response. In support of this, we found that inter-sample transcriptional heterogeneity increased with ageing. A decline in transcriptional fidelity is involved in the development of the senescence-associated secretory phenotype that contributes to inflammaging 39 . Both transcriptomic and proteomic analysis of cultures under mock infection suggests that airway inflammaging is retained in our model. The impairment of antiviral interferon responses is thought to occur as a consequence of this mild chronic inflammatory state 52 . Furthermore, transcriptomic changes associated with ageing may impact drug targets. In silico analyses identified that the proximity of many therapeutic drug classes to SARS-CoV-2 interacting proteins are similar between ages, suggesting effectiveness of them to be age-independent. Yet, identification of drug classes that are exclusively present in one age group, warrant consideration for successful discovery of therapeutics and repositioning of medications for COVID-19. While a larger cohort of participants, including those who have recovered from COVID-19, will be required to confirm our findings, our data offers a foundational view of the molecular changes associated with ageing that could help yield critical diagnostic markers for managing effective therapies. . For heatmaps colour key shows the relative expression (row Z-score; yellow, high; blue, low). * significantly upregulated (black) and downregulated (white) in SARS-CoV-2 infection relative to mock. (1) significantly upregulated and (2) downregulated relative to the two other age groups within the same condition. Mock, child hNEC, n = 5; child hBEC, n = 5, young adult, n = 4; older adult, n = 5; virus, child hNEC, n = 8; child hBEC, n = 5, young adult, n = 4; older adult, n = 6; two-tailed Wilcoxon rank sum test with Bonferroni correction. * adjusted p-value < 0.05, ** < 0.01, *** < 0.001, **** < 0.0001. Color indicates the age group and outline indicates condition. Statistical significance of the PCoA was performed with the adonis function within the vegan R package. Mock, child hNEC, n = 5; child hBEC, n = 5, young adult, n = 4; older adult, n = 5; virus, child hNEC, n = 8; child hBEC, n = 5, young adult, n = 4; older adult, n = 6; two-tailed Wilcoxon rank sum test with Bonferroni correction. For panels C, G, I and K: * adjusted p-value < 0.05, ** adjusted p-value < 0.01, *** adjusted p-value < 0.001, **** adjusted p-value < 0.0001. For heatmaps: * significantly upregulated (black) and downregulated (white) in SARS-CoV-2 infection relative to mock. (1) significantly upregulated and (2) downregulated relative to the two other age groups within the same condition. Drug classes with greater than two significantly proximal drugs. Size of bubble indicates number of significantly proximal drugs in each age group. Heatmap shows the mean proximity z-score of drugs within each drug class. Lower zscores indicates shorter proximity between drug class and SARS-CoV-2 interacting proteins. Z-score indicates drug efficacy. (C) Drug-target and SARS-CoV-2-human protein interaction network of all significantly proximal drugs across the older adult, young adult and child hNECs. Drug classes with drugs that were highly localised are highlighted. See Extended Figure 4A for network with annotated drugs and proteins. Network was produced with Cytoscape.

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China

Age-specific mortality and immunity patterns of SARS-CoV-2

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Heightened innate immune responses in the respiratory tract of COVID-19 patients

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

COVID-19 pandemic-A focused review for clinicians

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet infectious diseases

SARS-CoV-2 infection in children

Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses

The epidemiology of severe acute respiratory syndrome in the

Hong Kong epidemic: an analysis of all 1755 patients

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Double-stranded RNA sensors and modulators in innate immunity

Contribution of type III interferons to antiviral immunity: location, location, location

Interplay between SARS-CoV-2 and the type I interferon response

Activation and evasion of type I interferon responses by SARS-CoV-2

Cytokine storms: understanding COVID-19

Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells

Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Long-term clearance from small airways decreases with age

Oxidative stress associated with aging activates protein kinase Cε, leading to cilia slowing

The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Parsing the interferon transcriptional network and its disease associations

SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

Inflammaging and the Lung

An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide

A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells

Architecture of a SARS-CoV-2 mini replication and transcription complex

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Epigenetic mechanisms of longevity and aging

An integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action

DrugBank 5.0: a major update to the DrugBank database for

SARS-CoV-2 detection, viral load and infectivity over the course of an infection: SARS-CoV-2 detection, viral load and infectivity

Temporal dynamics in viral shedding and transmissibility of COVID-19

Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation

SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression in vivo

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production

Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation

IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function

SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology

Excessive neutrophils and neutrophil extracellular traps in COVID-19

Type I and type III interferons differ in their adjuvant activities for influenza vaccines

Reduced dynamic range of antiviral innate immune responses in aging